Research Updates

Back to feed
PubMed

Nov 12, 2026

Both-sided endocarditis in hereditary hemorrhagic telangiectasia: Weighing surgical risk against an unexplained bleeding phenotype.

View original source

Why it matters

This research is important because it highlights potential complications in treating patients with HHT and endocarditis and may influence discussions between patients and their healthcare providers about managing surgical risks and bleeding issues.

Objective

This study aims to explore the risks of surgery in patients with hereditary hemorrhagic telangiectasia (HHT) who have endocarditis, which is an infection of the heart's inner lining, and unusual bleeding issues.

Results

Results are not yet available as the full findings have not been published yet.

Methods

The researchers analyze cases of patients with HHT who developed endocarditis, focusing on their surgical outcomes and bleeding tendencies.

Limitations

Since no specific results are available and details are limited, we can't determine the effectiveness or safety of surgical procedures in these cases. Additionally, this topic is still being investigated with more studies needed.

For your doctor:

PMID: 43018153

DOI: 10.33963/v.phj.115734